Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin-Specific Protease 10: A New Target in Tumor Immune Escape. | Cancer Control | 2026 | 41711750 | PubTator, text mining | PubMed |
| Antagonistic Ubiquitin Switching by USP7 and RNF40 Orchestrates KDM6A Homeostasis to License Coronavirus Susceptibility. | Adv Sci (Weinh) | 2026 | 41691482 | PubTator, text mining | PubMed |
| Clinical significance and mechanistic role of Hsa_circ_0005075 in recurrent spontaneous abortion: Regulation of trophoblast proliferation and invasion through the Wnt/β-catenin pathway. | Clinics (Sao Paulo) | 2026 | 41690268 | PubTator, text mining | PubMed |
| Ubiquitin control of cytosolic DNA sets immune responses to DNA damage. | Cancer Cell | 2026 | 41666875 | PubTator, text mining | PubMed |
| PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis. | Metabolism | 2026 | 41655956 | PubTator, text mining | PubMed |
| Bypass of blocking lesions by RNAPII reveals a novel stress induced by DNA damage. | Genes Dev | 2026 | 41644268 | PubTator, text mining | PubMed |
| USP7 protects histone H1.2 from proteasome-mediated degradation to facilitate DNA repair and pancreatic neuroendocrine neoplasms progression. | Sci China Life Sci | 2026 | 41639524 | PubTator, text mining | PubMed |
| Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets. | PeerJ | 2026 | 41635813 | PubTator, text mining | PubMed |
| Toosendanin sensitizes hepatocyte ferroptosis via dual inhibition of Nrf2 O-GlcNAcylation and USP7-driven deubiquitination. | Toxicon | 2026 | 41628670 | PubTator, text mining | PubMed |
| Multi-omics integration in deciphering non-small cell lung cancer drug resistance: current status, challenges, and future prospects. | Hereditas | 2026 | 41622239 | PubTator, text mining | PubMed |
| Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade. | Cell Death Differ | 2026 | 41617976 | PubTator, text mining | PubMed |
| The role of HMGA1 in genome stability: Implications in human cancer. | Cell Mol Life Sci | 2026 | 41586900 | PubTator, text mining | PubMed |
| Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression. | Cell Death Dis | 2026 | 41565619 | PubTator, text mining | PubMed |
| USP7 Stabilizes MESP1 To Promote the Malignant Progression of Non-Small Cell Lung Cancer. | Appl Biochem Biotechnol | 2026 | 41563568 | PubTator, text mining | PubMed |
| Proteasomal proteolysis in p62 condensates directs tumor suppression or growth depending on their subcellular localization. | Proc Natl Acad Sci U S A | 2026 | 41543905 | PubTator, text mining | PubMed |
| Study on epigenetic regulatory mechanism of MBD4 with a germline loss-of-function mutation (rs140693) responsible for retinoblastoma chemoresistance via the cell cycle and apoptotic pathways. | Pharmacol Res | 2026 | 41534805 | PubTator, text mining | PubMed |
| Computational modeling of ubiquitin specific protease 7 (USP7) complexes with N-benzylpiperidinol derivatives incorporating binding site flexibility. | J Mol Graph Model | 2026 | 41520442 | PubTator, text mining | PubMed |
| Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage. | Cancer Cell | 2026 | 41512867 | PubTator, text mining | PubMed |
| Histone 3 lysine 56 acetylation (H3K56ac) regulates extrachromosomal DNA (ecDNA) hub maintenance. | Neoplasia | 2026 | 41496274 | PubTator, text mining | PubMed |
| LncRNA FOXP4-AS1 facilitates colorectal cancer invasion and migration by enhancing USP7 interaction with ZEB1. | Sci Rep | 2026 | 41486276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=7